跳转至内容
Merck
CN

AST1002

Sigma-Aldrich

Astrocytes, Mature, CTRL Line

IPSC derived

登录查看公司和协议定价

选择尺寸


关于此项目

UNSPSC代码:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

生物来源

human

生长模式

Adherent

核型

2n=46

形态学

elongated, flat, astrocytic

运输

dry ice

储存温度

−196°C

应用

These products provide unique and versatile tools for the study of central nervous system (CNS) disorders, such as Alzheimer′s disease (AD), Parkinson′s disease (PD), autism, schizophrenia, and amyotrophic lateral sclerosis (ALS), as well as for drug screening and toxicology applications in the neural space.

生化/生理作用

Control line, derived from integration free made iPSC line, mature astrocytes

特点和优势

This product contains cryo-preserved, pre-differentiated astrocytes derived from a footprint-free, karyotype normal human iPSC line. It was designed for customers to generate mature astrocytes using the optimized maturation medium and supplements (AST1050, AST1051 sold separately). Mature astrocytes can be obtained within 17 days. Shortly after seeding and recovery, the cells proliferate and need to be passaged a minimum of two times. In general, at 17 days post-seeding, the cell population will contain ≥80% Glial Fibrillary Acidic Protein (GFAP) positive astrocytes and ≤15% Tuj-1 positive neurons (neuronal class III β-tubulin).

制备说明

The cells need to be passaged a minimum of two times. See technical bulletin for additional details.
User must also purchase Astrocyte Maturation Medium, AST1050 (50mL) or AST1051 (250mL). Sold separately.

储存分类代码

10 - Combustible liquids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Efficient generation of astrocytes from human pluripotent stem cells in defined conditions.
Shaltouki A, Peng J, Liu Q, Rao MS, Zeng X.
Stem Cells, 31, 941-952 (2013)
Yiping Yan et al.
Stem cells translational medicine, 2(11), 862-870 (2013-10-12)
Human pluripotent stem cells (hPSCs), including human embryonic stem cells and human induced pluripotent stem cells, are unique cell sources for disease modeling, drug discovery screens, and cell therapy applications. The first step in producing neural lineages from hPSCs is

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持